Pfizer Recalls 1 Million Birth Control Pill Packages
Written By: Rheingold, Valet, Rheingold, Ruffo & Giuffra LLP
Pfizer announced today that it is recalling a over million birth control pills after it recently found out about an error in the packaging. Some of the packages of Lo/Ovral and Norgestrel and Ethinyl Estradiol contained too many or too few active birth control pills. These pills were marketed in the US by Akrimax Pharmaceuticals or Akrimax Rx Products.
Typically the 28 day packages contain 21 active birth control pills and 7 placebo pills. Some of the packages were found to have more than 7 placebo pills while others were found to have less than 7 placebo pills. In total 28 lots of the birth control were recalled totalling over 1 million packages.
Too many placebo pills could mean women will develop unintended pregnancies. Patients with affected lots have been advised to use other, non-hormonal, contraceptives until they can take their normal birth control as usual.
Our firm is deeply involved in two active birth control litigations, Yaz/Beyaz/Yasmin/Ocellaand NuvaRing. Currently the Yaz litigation in both the Multidistrict Litigation and the New Jersey state consolidated litigation are on hold pending possible settlement negotiations.